JP2025509446A5 - - Google Patents
Info
- Publication number
- JP2025509446A5 JP2025509446A5 JP2024553877A JP2024553877A JP2025509446A5 JP 2025509446 A5 JP2025509446 A5 JP 2025509446A5 JP 2024553877 A JP2024553877 A JP 2024553877A JP 2024553877 A JP2024553877 A JP 2024553877A JP 2025509446 A5 JP2025509446 A5 JP 2025509446A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- substituted
- independently
- formula
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263269209P | 2022-03-11 | 2022-03-11 | |
| US63/269,209 | 2022-03-11 | ||
| US202363479938P | 2023-01-13 | 2023-01-13 | |
| US63/479,938 | 2023-01-13 | ||
| PCT/US2023/064202 WO2023173131A2 (en) | 2022-03-11 | 2023-03-11 | Organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025509446A JP2025509446A (ja) | 2025-04-11 |
| JP2025509446A5 true JP2025509446A5 (https=) | 2026-03-19 |
Family
ID=87936112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553877A Pending JP2025509446A (ja) | 2022-03-11 | 2023-03-11 | 有機化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250186446A1 (https=) |
| EP (1) | EP4489758A4 (https=) |
| JP (1) | JP2025509446A (https=) |
| KR (1) | KR20240158980A (https=) |
| AU (1) | AU2023232171A1 (https=) |
| CA (1) | CA3243686A1 (https=) |
| MX (1) | MX2024010993A (https=) |
| WO (1) | WO2023173131A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020146384A1 (en) | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20220054853A (ko) | 2019-09-03 | 2022-05-03 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치료 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120012831A (ko) * | 2007-12-06 | 2012-02-10 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| KR102240326B1 (ko) * | 2013-03-15 | 2021-04-13 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| CA2991628C (en) * | 2015-07-16 | 2020-04-07 | Bioxcel Therapeutics, Inc. | A novel approach for treatment of cancer using immunomodulation |
| JP7134168B6 (ja) * | 2016-09-12 | 2024-02-02 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 新規使用 |
| EP3558319A4 (en) * | 2016-12-22 | 2020-07-22 | AbbVie Inc. | COMPOSITIONS AND PROCESSES FOR IMPROVING OR INCREASING THE PRODUCTION OF TYPE I IFN |
| MX2020012628A (es) * | 2018-05-25 | 2021-01-29 | Intra Cellular Therapies Inc | Compuestos organicos. |
| WO2020146384A1 (en) * | 2019-01-07 | 2020-07-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20220054853A (ko) * | 2019-09-03 | 2022-05-03 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치료 방법 |
-
2023
- 2023-03-11 MX MX2024010993A patent/MX2024010993A/es unknown
- 2023-03-11 US US18/846,037 patent/US20250186446A1/en active Pending
- 2023-03-11 JP JP2024553877A patent/JP2025509446A/ja active Pending
- 2023-03-11 AU AU2023232171A patent/AU2023232171A1/en active Pending
- 2023-03-11 CA CA3243686A patent/CA3243686A1/en active Pending
- 2023-03-11 WO PCT/US2023/064202 patent/WO2023173131A2/en not_active Ceased
- 2023-03-11 KR KR1020247033626A patent/KR20240158980A/ko active Pending
- 2023-03-11 EP EP23767772.9A patent/EP4489758A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220339169A1 (en) | Methods of treating or selecting a treatment for a subject resistant to tnf inhibitor using a nlrp3 antagonist | |
| US8642602B2 (en) | Method of inhibiting fibrogenesis and treating fibrotic disease | |
| JP2025509446A5 (https=) | ||
| JP2021526133A5 (https=) | ||
| EP3311841B1 (en) | Anticancer agent | |
| JP2020505396A5 (https=) | ||
| JP6063392B2 (ja) | 自己免疫性障害または臓器免疫拒絶による苦痛を治療するための、インドールアミン−２，３−ジオキシゲナーゼ（ｉｄｏ）を誘導する少なくとも２つの化合物を含んでなる組成物 | |
| JP2021513518A5 (https=) | ||
| JP2018533560A (ja) | 癌を治療するための併用療法 | |
| JP7089603B2 (ja) | 眼疾患を治療するための脱メチル化 | |
| JP5344764B2 (ja) | 黄斑変性におけるオロチン酸カルボキシアミドトリアゾール（ｃａｉ）の使用方法 | |
| JP2022533981A5 (https=) | ||
| TW202313559A (zh) | 組蛋白去乙醯化酶6和熱休克蛋白90之雙重抑制劑 | |
| JP2022546711A5 (https=) | ||
| JP5679582B2 (ja) | 線維性障害を処置する方法 | |
| US20190255153A1 (en) | Interferon Therapy | |
| JP2025509446A (ja) | 有機化合物 | |
| CN116322674B (zh) | 用于根除癌症干细胞并诱导damp介导的抗肿瘤免疫反应的一组新型copi/arf1-脂解途径抑制剂和化合物 | |
| JP7370109B2 (ja) | 新規化合物およびその自己免疫疾患の治療用途 | |
| JPH09510198A (ja) | キノリン−３−カルボキシアミド化合物の新規な使用 | |
| JP2026500719A (ja) | アルファ－ｖ－ベータ－８インテグリン阻害剤及びその使用 | |
| WO2024059878A2 (en) | Drugs targeting telomerase reverse transcriptase (tert) for treatment of cancers | |
| KR20220011562A (ko) | 급성 골수성 백혈병에서의 재발 위험 감소 및 생존 연장을 위한 방법 및 조성물 | |
| WO2024130696A1 (zh) | 精胺在预防和治疗炎症性疾病中的用途 | |
| US20050054095A1 (en) | Use of l-$g(a)-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vivo |